Desmoplastic Small Round Cell Tumor clinical trials
14 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
- Lurbinectedin in FET-Fused Tumors
- Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
- Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
- Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
- Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
- Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
- PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
- Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Desmoplastic Small Round Cell Tumor” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.